Orchid Pharma Gets Seven Observations from US FDA After Alathur, India Unit Inspection

MT Newswires Live

2025/02/20

Orchid Pharma (NSE:ORCHPHARMA, BOM:524372) received seven observations from the US Food and Drug Administration (US FDA) after a surprise inspection at its active pharmaceutical ingredient manufacturing facility at Alathur in Tamil Nadu, India, according to a Wednesday filing to the Indian stock exchanges.

The inspection was conducted from Feb. 10 to Feb. 18, which the company said "resulted in seven minor observations, none of which pertain to the data integrity of the facility."

The Alathur facility specializes in producing Cephalosporin antibiotics, a critical class of life-saving drugs.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2512646521"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2512646521\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2512646521?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-02-20 10:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2512646521","market":"sg","top_or_hot":-1,"title":"Orchid Pharma Gets Seven Observations from US FDA After Alathur, India Unit Inspection","media":"MT Newswires Live","content":"<html><body><p> Orchid Pharma (NSE:ORCHPHARMA, BOM:524372) received seven observations from the US Food and Drug Administration (US FDA) after a surprise inspection at its active pharmaceutical ingredient manufacturing facility at Alathur in Tamil Nadu, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The inspection was conducted from Feb. 10 to Feb. 18, which the company said \"resulted in seven minor observations, none of which pertain to the data integrity of the facility.\"</p><p>The Alathur facility specializes in producing Cephalosporin antibiotics, a critical class of life-saving drugs.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Orchid Pharma Gets Seven Observations from US FDA After Alathur, India Unit Inspection</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOrchid Pharma Gets Seven Observations from US FDA After Alathur, India Unit Inspection\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-02-20 10:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Orchid Pharma (NSE:ORCHPHARMA, BOM:524372) received seven observations from the US Food and Drug Administration (US FDA) after a surprise inspection at its active pharmaceutical ingredient manufacturing facility at Alathur in Tamil Nadu, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The inspection was conducted from Feb. 10 to Feb. 18, which the company said \"resulted in seven minor observations, none of which pertain to the data integrity of the facility.\"</p><p>The Alathur facility specializes in producing Cephalosporin antibiotics, a critical class of life-saving drugs.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OTS.SI","symbol_name":"OTS Holdings","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2512646521","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2512646521","pubTimestamp":1740019126,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Orchid Pharma  received seven observations from the US Food and Drug Administration  after a surprise inspection at its active pharmaceutical ingredient manufacturing facility at Alathur in Tamil Nadu, India, according to a Wednesday filing to the Indian stock exchanges.The inspection was conducted from Feb. 10 to Feb. 18, which the company said \"resulted in seven minor observations, none of which pertain to the data integrity of the facility.\"The Alathur facility specializes in producing Cephalosporin antibiotics, a critical class of life-saving drugs.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OTS.SI":"OTS Holdings","BK6509":"食品和饮料股","BK6114":"包装食品与肉类"},"translate_title":"Orchid Pharma在印度阿拉瑟单位检查后收到美国FDA的七项观察结果","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTS.SI":1},"content_text":"Orchid Pharma (NSE:ORCHPHARMA, BOM:524372) received seven observations from the US Food and Drug Administration (US FDA) after a surprise inspection at its active pharmaceutical ingredient manufacturing facility at Alathur in Tamil Nadu, India, according to a Wednesday filing to the Indian stock exchanges.The inspection was conducted from Feb. 10 to Feb. 18, which the company said \"resulted in seven minor observations, none of which pertain to the data integrity of the facility.\"The Alathur facility specializes in producing Cephalosporin antibiotics, a critical class of life-saving drugs.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}